News - Unibest Industrial Co., Ltd.

Blogs

Welcome to Unibest's Blogs section! Here, you will find valuable insights and in-depth reports covering various topics related to drugs and diseases. Our blogs aim to provide an enhanced understanding of the clinical significance and breakthroughs your clients can make. Stay updated with the latest trends, technological advancements, and industry analyses as we dive deep into the world of pharmaceuticals, giving you the knowledge and resources you need to stay ahead of the competition.

Seizing the Opportunity in the CGRP Targeting Drugs Market
2024-02-04

The global pharmaceutical landscape is witnessing a remarkable surge in the development and approval of drugs targeting trigeminal neuropeptide calcitonin gene-related peptide (CGRP) or its receptor, especially for treating migraine, a debilitating neurological disorder affecting a substantial adult Read More
The Magic Bullet in the Synthesis? - Well, Name Goes to the Molecular Building Blocks
2024-01-24

Molecular building blocks, also known as organic building blocks, are functionalized molecules that serve as the foundational components for organic synthesis. Utilized for bottom-up modular assembly, they enable the construction of molecular architectures such as supramolecular complexes, metal-org Read More
Two Decades of Sustainable Development, a Message from the Founder
2024-01-19

Dear colleagues and families,Good evening!Today, we gather together to celebrate the 20th anniversary of Unibest.First and foremost, I want to express my deepest gratitude for your unwavering support and colossal contributions! It’s because of you all that Unibest has achieved every bit of success. Read More
Peptide 101: A Deep Dive into Peptide Drug Market, Development Timeline, and Strategies in Delivery
2024-01-18

While everything from dietary changes to high-cost surgeries has been explored to combat diseases, therapeutics derived from peptides have risen as a powerful strategy. Over the past few years, peptide drugs have swept through the pharmaceutical market, redefining treatment approaches for various di Read More
The STNG Pathway and drug development
2024-01-17

A Novel Target: The STING PathwayInfection, cancer, and cellular damages often results in mislocalized dsDNA within the cell.The STING (Stimulator of Interferon Genes) signaling pathway is triggered through innate cyclic GMP-AMP synthase (cGAS) activation, giving the molecule cGAMP.2', 3' - cGAMP mo Read More
Market Analysis of Vibegron for the Treatment of Overactive Bladder
2024-01-02

Prevalence of OABAccording to Statistic Brain, an estimated 183 million people worldwide suffer from overactive bladder (OAB), with North America having the highest prevalence. In the U.S. alone, around 66.6 million people experience OAB symptoms, suggesting a significant market potential for OAB tr Read More
Overactive Bladder: An Overview for Global Drug Company BDs And VPs
2023-12-01

Overactive Bladder (OAB) is a common urological condition, with significant impacts on patients' quality of life and substantial economic implications for the healthcare market. For stakeholders in the pharmaceutical industry - particularly those targeting the urology market - it's crucial to unders Read More
The overlooked opportunity in heart health: Generic EPA
2023-11-30

Heart disease continues to be the primary cause of death globally, claiming upwards of 17 million lives each year. Statins have evolved as an acceptable course for reducing LDL cholesterol and cardiovascular risk. Yet, a significant residual risk remains. With the increasing prevalence of obesity, d Read More
Combating Antibiotic Resistance in Veterinary Medicine with Mechanochemistry
2023-11-16

Antibiotic resistance is a growing global health crisis, making infections harder to treat and increasing healthcare costs. As we recognize World Antimicrobial Awareness Week, it's important to consider how this problem impacts both human medicine and veterinary medicine. Animals and humans share ma Read More